PERCEPTIVE ADVISORS LLC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1224962
NEW YORK, NY
Position in PRAX
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$655,974,329
+$67,677,416 QoQ
Shares Held
2,035,986
+2.0% QoQ
Ownership
7.30%
of shares outstanding
% of Portfolio
13.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Derivatives in PRAX
reported options exposure · as of Dec 31, 2024CallValue
$38,480,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,570,707,559 across 67 Biotechnology names. PRAX ranks #1 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in PRAX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $655,974,329 | 2,035,986 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $588,296,913 | 1,995,986 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $82,921,362 | 1,564,554 | Shares | Sole | 2025-11-14 | |
| 2025-07-15 | $70,700,280 | 1,362,503 | Shares | Sole | 2025-07-22 | |
| 2025-06-30 | $31,660,328 | 752,921 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,146,455 | 980,894 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $38,480,000 | 500,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $102,336,405 | 1,329,735 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $66,978,573 | 1,164,035 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,029,512 | 750,230 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $50,133,360 | 821,589 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||